Try our Advanced Search for more refined results

GSK Forks Up $105M To End States' Off-Label Marketing Suits

By Juan-Carlos Rodriguez (June 4, 2014, 2:15 PM EDT) -- GlaxoSmithKline PLC said on Wednesday it has reached settlements totaling $105 million with 44 states and the District of Columbia, resolving allegations that the company improperly marketed and promoted the asthma drug Advair and the antidepressant drugs Paxil and Wellbutrin....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!